Total Payments
$1.0M
2024 Payments
$141,011
Companies
35
Transactions
1,317
Medicare Patients
2,833
Medicare Billing
$140,369
Payment Breakdown by Category
Other$832,092 (81.4%)
Travel$102,525 (10.0%)
Consulting$30,833 (3.0%)
Food & Beverage$29,746 (2.9%)
Research$26,000 (2.5%)
Education$826.68 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $807,702 | 342 | 79.0% |
| Travel and Lodging | $102,525 | 368 | 10.0% |
| Consulting Fee | $30,833 | 16 | 3.0% |
| Food and Beverage | $29,746 | 573 | 2.9% |
| Unspecified | $26,000 | 1 | 2.5% |
| Honoraria | $24,390 | 11 | 2.4% |
| Education | $826.68 | 6 | 0.1% |
Payments by Type
General
$996,023
1,316 transactions
Research
$26,000
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| LANTHEUS MEDICAL IMAGING, INC. | $378,150 | 527 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $200,439 | 171 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $141,545 | 145 | $0 (2024) |
| Amgen Inc. | $111,212 | 195 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $62,481 | 92 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $35,895 | 37 | $0 (2019) |
| Bracco Diagnostics Inc. | $28,990 | 27 | $0 (2024) |
| BIOTRONIK INC. | $26,000 | 1 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $23,250 | 23 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $3,000 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $141,011 | 148 | Kiniksa Pharmaceuticals International, plc ($58,763) |
| 2023 | $225,881 | 250 | E.R. Squibb & Sons, L.L.C. ($102,018) |
| 2022 | $158,899 | 181 | Lantheus Medical Imaging, Inc. ($50,493) |
| 2021 | $63,398 | 94 | Lantheus Medical Imaging, Inc. ($35,825) |
| 2020 | $56,091 | 71 | Lantheus Medical Imaging, Inc. ($31,015) |
| 2019 | $75,825 | 126 | Lantheus Medical Imaging, Inc. ($28,164) |
| 2018 | $143,637 | 265 | Lantheus Medical Imaging, Inc. ($87,790) |
| 2017 | $157,280 | 182 | Lantheus Medical Imaging, Inc. ($62,604) |
All Payment Transactions
1,317 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Genetic Disease | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: Cardiology | ||||||
| 11/26/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $934.00 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $45.85 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | Cash or cash equivalent | $38.35 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $24.00 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $23.45 | General |
| Category: Cardiology | ||||||
| 11/17/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $54.54 | General |
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $106.22 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $505.24 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $248.00 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $94.00 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $75.46 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | In-kind items and services | $753.24 | General |
| Category: Cardiology | ||||||
| 11/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,690.00 | General |
| Category: Rheumatology | ||||||
| 11/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $122.35 | General |
| Category: Rheumatology | ||||||
| 11/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,690.00 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,680.00 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $435.19 | General |
| Category: Rheumatology | ||||||
| 10/18/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Travel and Lodging | In-kind items and services | $399.32 | General |
| Category: CONTRAST AGENT | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,690.00 | General |
| Category: Rheumatology | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $245.58 | General |
| Category: Rheumatology | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Travel and Lodging | Cash or cash equivalent | $164.36 | General |
| Category: Rheumatology | ||||||
| 10/15/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Rheumatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TIME AND MOTION STUDY BIEDERMAN | BIOTRONIK INC. | $26,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 525 | 541 | $106,964 | $24,779 |
| 2022 | 11 | 743 | 788 | $157,275 | $36,083 |
| 2021 | 13 | 802 | 871 | $185,454 | $41,513 |
| 2020 | 13 | 763 | 839 | $160,169 | $37,994 |
Total Patients
2,833
Total Services
3,039
Medicare Billing
$140,369
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 375 | 383 | $77,816 | $18,820 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 36 | 39 | $14,484 | $2,457 | 17.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 17 | $5,304 | $1,412 | 26.6% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2023 | 15 | 15 | $5,450 | $1,107 | 20.3% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 28 | 30 | $2,178 | $543.76 | 25.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 18 | 19 | $984.00 | $262.70 | 26.7% |
| 75565 | Mri scan of blood flow of heart | Facility | 2023 | 15 | 15 | $525.00 | $121.16 | 23.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 22 | 23 | $223.00 | $54.88 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 416 | 437 | $93,446 | $21,258 | 22.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 52 | 70 | $25,680 | $5,832 | 22.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 32 | 32 | $9,980 | $2,629 | 26.3% |
| 75561 | Mri scan of heart before and after contrast | Facility | 2022 | 23 | 23 | $9,517 | $2,190 | 23.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 12 | $6,366 | $1,390 | 21.8% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 51 | 57 | $5,046 | $1,078 | 21.4% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2022 | 39 | 39 | $2,808 | $687.65 | 24.5% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 35 | 35 | $1,924 | $483.21 | 25.1% |
| 75565 | Mri scan of blood flow of heart | Facility | 2022 | 28 | 28 | $1,256 | $267.60 | 21.3% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2022 | 19 | 19 | $694.00 | $180.90 | 26.1% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 36 | 36 | $558.00 | $86.38 | 15.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 489 | 511 | $118,552 | $26,005 | 21.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 68 | $25,160 | $6,000 | 23.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 20 | $10,360 | $2,306 | 22.3% |
| 75561 | Mri of heart before and after contrast | Facility | 2021 | 21 | 21 | $9,807 | $2,118 | 21.6% |
| 93312 | Insertion of probe in esophagus for heart ultrasound examination including interpretation and report | Facility | 2021 | 25 | 25 | $7,625 | $2,025 | 26.6% |
| 93308 | Follow-up or limited ultrasound examination of heart | Facility | 2021 | 39 | 40 | $4,400 | $771.40 | 17.5% |
About Dr. Robert Biederman, MD
Dr. Robert Biederman, MD is a Cardiovascular Disease healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912907734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Biederman, MD has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $141,011 received in 2024. These payments were reported across 1,317 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($807,702).
As a Medicare-enrolled provider, Biederman has provided services to 2,833 Medicare beneficiaries, totaling 3,039 services with total Medicare billing of $140,369. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Charleston, SC
- Active Since 07/22/2005
- Last Updated 02/16/2024
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1912907734
Products in Payments
- DEFINITY (Drug) $199,593
- Definity (Drug) $178,557
- CAMZYOS (Drug) $165,484
- Arcalyst (Drug) $140,066
- Repatha (Biological) $110,539
- XARELTO (Drug) $62,481
- PRALUENT (Drug) $30,975
- PRALUENT ALIROCUMAB INJECTION (Biological) $23,208
- ISOVUE (Drug) $12,832
- MR (Group) (Drug) $11,278
- Isovue (Drug) $4,676
- DISEASE STATE (Drug) $3,805
- Veltassa (Drug) $2,941
- PRADAXA (Drug) $2,415
- MULTAQ (Drug) $1,115
- WATCHMAN (Device) $734.68
- ZYPITAMAG (pitavastatin) (Drug) $634.90
- ENTRESTO (Drug) $570.75
- Product in Development (Device) $350.00
- ELIQUIS (Drug) $324.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Charleston
Jeffrey Winterfield, M.d, M.D
Cardiovascular Disease — Payments: $549,685
Cardiovascular Disease $549,685
Frank Cuoco, Md, MD
Cardiovascular Disease — Payments: $292,531
Cardiovascular Disease $292,531
Sarah Rinehart, Md, MD
Cardiovascular Disease — Payments: $198,204
Cardiovascular Disease $198,204
Daniel Judge, M.d, M.D
Cardiovascular Disease — Payments: $165,251
Cardiovascular Disease $165,251
Dr. Sheldon Litwin, M.d, M.D
Cardiovascular Disease — Payments: $153,640
Cardiovascular Disease $153,640
Dr. Geetha Pinto, Md, MD
Cardiovascular Disease — Payments: $127,703
Cardiovascular Disease $127,703